These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15940337)

  • 41. Effect of intravenous insulin administration on left ventricular performance during non-ST-elevation acute coronary events in patients with diabetes mellitus.
    Stefanidis A; Melidonis A; Tournis S; Zairis M; Handanis S; Beldekos D; Argyrakis S; Asimacopoulos P; Foussas S
    Am J Cardiol; 2003 May; 91(10):1237-40. PubMed ID: 12745109
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of oral antidiabetics and insulin on lipids and coronary heart disease in non-insulin-dependent diabetes mellitus.
    Hanefeld M; Temelkova-Kurktschiev T; Köhler C
    Ann N Y Acad Sci; 1997 Sep; 827():246-68. PubMed ID: 9329759
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral pharmacologic treatment of type 2 diabetes mellitus.
    Richard T; Brohee D; Van Meerhaeghe A; Vanhaeverbeek M
    Ann Intern Med; 2012 Jul; 157(1):76; author reply 76-7. PubMed ID: 22751769
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral pharmacologic treatment of type 2 diabetes mellitus.
    Rodbard HW; Jellinger PS
    Ann Intern Med; 2012 Jul; 157(1):75-6; author reply 76-7. PubMed ID: 22751768
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral pharmacologic treatment of type 2 diabetes mellitus.
    Moskowitz RS
    Ann Intern Med; 2012 Jul; 157(1):75; author reply 76-7. PubMed ID: 22751767
    [No Abstract]   [Full Text] [Related]  

  • 46. Single-composition extended-release metformin hydrochloride. A viewpoint by Vivian Fonseca.
    Fonseca V
    Treat Endocrinol; 2004; 3(5):333-4. PubMed ID: 15330684
    [No Abstract]   [Full Text] [Related]  

  • 47. Single-composition extended-release metformin hydrochloride. A viewpoint by David Bell.
    Bell D
    Treat Endocrinol; 2004; 3(5):333. PubMed ID: 15330683
    [No Abstract]   [Full Text] [Related]  

  • 48. Glumetza: once-a-day dosing for management of type 2 diabetes.
    Laustsen G
    Nurse Pract; 2006 May; 31(5):50-1. PubMed ID: 16680087
    [No Abstract]   [Full Text] [Related]  

  • 49. Metformin and prognosis of critical illness: a question of timing?
    Christiansen CF
    Crit Care; 2013; 17(6):471. PubMed ID: 25320755
    [No Abstract]   [Full Text] [Related]  

  • 50. Metformin improves survival in intensive care unit patients, but why?
    Riksen NP; Rongen GA; Pickkers P
    Crit Care; 2013 Dec; 17(6):471. PubMed ID: 24330731
    [No Abstract]   [Full Text] [Related]  

  • 51. Collaborative care for depression in diabetes: Challenges, opportunities and strategies.
    Patra S; Patro BK
    Natl Med J India; 2018; 31(2):124. PubMed ID: 30829237
    [No Abstract]   [Full Text] [Related]  

  • 52. Lifestyle intervention in postmenopausal women: winning the game against diabetes.
    Wellons M
    Menopause; 2011 Aug; 18(8):837-8. PubMed ID: 21712731
    [No Abstract]   [Full Text] [Related]  

  • 53. Risks of Prescription Sharing.
    Sarwal A; Menon V; Gnanasekaran I
    Am J Med Sci; 2019 Dec; 358(6):433-434. PubMed ID: 31653322
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapeutic action of acetylcholine delayed combined with BZ 55 and D-860 in diabetes mellitus].
    TORRES GONZALEZ G; CONDE GARGOLLO E; BLANCO SOLER ROS C; SANCHEZ PEREZ JL; MENENDEZ I
    Rev Iber Endocrinol; 1958; 5(29):553-61. PubMed ID: 13602310
    [No Abstract]   [Full Text] [Related]  

  • 55. [On the history of antidiabetics].
    Bänder A
    Ther Ggw; 1967 Jan; 106(1):103-6. PubMed ID: 6043571
    [No Abstract]   [Full Text] [Related]  

  • 56. [Protracted dosage & differences in valence of oral antidiabetics & insulin need after their unsuccessful administration].
    CHRISTOFFEL P
    Medizinische; 1959 Mar; 4(10):414-7. PubMed ID: 13643489
    [No Abstract]   [Full Text] [Related]  

  • 57. [Methods for preventing accumulation of oral antidiabetics].
    LEYPOLD F
    Wien Klin Wochenschr; 1958 Feb; 70(7):123-4. PubMed ID: 13544244
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmacotherapeutic reviews. XXII. Insulin and oral antidiabetics].
    Ned Tijdschr Geneeskd; 1966 Apr; 110(14):684-8. PubMed ID: 5327735
    [No Abstract]   [Full Text] [Related]  

  • 59. [Optimising treatment of type-2 diabetes: adjusting the treatment to both patient and illness].
    Artola Menéndez S
    Aten Primaria; 2003 Feb; 31(2):109-13. PubMed ID: 12609109
    [No Abstract]   [Full Text] [Related]  

  • 60. [Respective indications for insulin and synthetic hypoglycemic agents in diabetes mellitus].
    QUICHAUD J
    Vie Med; 1963 May; 44():109-14. PubMed ID: 13972743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.